Peripheral Arterial Disease Trial, Recruiting (NCT05830721)

Peripheral Arterial Disease Trial, Recruiting NCT05830721 Sponsor: Johns Hopkins University Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05830721 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be an adult aged 18 or older
You must be receiving a type of life support called peripheral venoarterial ECMO (a machine that helps the heart and lungs by pumping blood outside the body through tubes inserted into blood vessels)
You must be sedated (in a medically induced sleep) at the time of the trial

Who may not be able to join:

You have been diagnosed with reduced blood flow to a limb (such as an arm or leg) before the ECMO support was started
You have a serious injury to a limb that would make it impossible to insert the trial's device
You are considered to have a very poor outlook, meaning doctors do not expect you to survive beyond 72 hours — this also includes people with severe problems with blood clotting, as these individuals may be at high risk of dangerous bleeding (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Babar Shafiq, MD, MSPT, Johns Hopkins University

Phone: 2408050284

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05830721

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 2408050284

More information: https://clinicaltrials.gov/study/NCT05830721

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be an adult aged 18 or older
You must be receiving a type of life support called peripheral venoarterial ECMO (a machine that helps the heart and lungs by pumping blood outside the body through tubes inserted into blood vessels)
You must be sedated (in a medically induced sleep) at the time of the trial

Who may not be able to join:

You have been diagnosed with reduced blood flow to a limb (such as an arm or leg) before the ECMO support was started
You have a serious injury to a limb that would make it impossible to insert the trial's device
You are considered to have a very poor outlook, meaning doctors do not expect you to survive beyond 72 hours — this also includes people with severe problems with blood clotting, as these individuals may be at high risk of dangerous bleeding (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

2 January 2024

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Participants with Diagnosed Compartment syndrome; Number of Participants that Require Amputation; Number of Deaths During Hospitalization; Number of Participants with Amputation-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov